News brief­ing: Seer heads to Nas­daq with $150M IPO; IN8bio post­pones pub­lic de­but amid record year on Wall Street

Less than four months af­ter a $55 mil­lion raise, Seer is ready to go pub­lic.

The com­pa­ny, run by Omid Farokhzad, filed for a $150 mil­lion IPO on Thurs­day as it pre­pares to jump on­to the Nas­daq. Seer’s stock tick­er will be fair­ly sim­ple to re­mem­ber — $SEER — and the move comes af­ter the com­pa­ny has raised more than $150 mil­lion since be­ing found­ed in 2017.

Thurs­day’s news al­so comes less than a month af­ter Seer’s main prod­uct, the Pro­teo­graph Prod­uct Suite, was de­liv­ered to one of its first col­lab­o­ra­tors, per the com­pa­ny’s S-1. Funds from the IPO will go to­ward fur­ther com­mer­cial­iz­ing the prod­uct and oth­er R&D-re­lat­ed projects for Pro­teo­graph.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.